United States
Print page content Print
Increase text size Decrease text size
Text Size

EQUIVAC® INNOVATOR EHV-1/4

EQUIVAC® INNOVATOR EHV-1/4 is for the vaccination of healthy horses as an aid in the prevention of equine rhinopneumonitis due to types 1 and 4 viruses.

Collapse All
  • Protection against upper-respiratory disease should include vaccination for EHV-1 and EHV4.

  • Horses, inject one 1 mL dose intramuscularly using aseptic technique.

    Administer a second 1 mL dose 3 to 4 weeks after the first dose.

    A 1 mL booster dose should be given annually.


PRECAUTIONS: Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter.

In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only